Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Aptevo Therapeutics Current Ratio 2014-2019 | APVO

Aptevo Therapeutics current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Aptevo Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.04B $0.04B 0.99
2019-06-30 $0.04B $0.02B 2.63
2019-03-31 $0.06B $0.02B 3.15
2018-12-31 $0.05B $0.02B 2.77
2018-09-30 $0.06B $0.02B 3.91
2018-06-30 $0.07B $0.02B 3.66
2018-03-31 $0.08B $0.02B 4.47
2017-12-31 $0.10B $0.02B 5.14
2017-09-30 $0.12B $0.02B 7.76
2017-06-30 $0.07B $0.01B 5.66
2017-03-31 $0.08B $0.01B 5.35
2016-12-31 $0.07B $0.02B 3.65
2016-09-30 $0.08B $0.02B 5.21
2016-06-30 $0.04B $0.02B 2.34
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B 0.00
2015-09-30 $0.00B 0.00
2015-06-30 $0.00B 0.00
2014-12-31 $0.04B $0.02B 2.10
2013-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.023B $0.023B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.754B 14.95
CSL (CSLLY) Australia $100.067B 0.00
Gilead Sciences (GILD) United States $84.777B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.762B 57.87
Biogen (BIIB) United States $58.677B 10.02
Illumina (ILMN) United States $44.088B 45.58
Regeneron Pharmaceuticals (REGN) United States $43.749B 18.53
Alexion Pharmaceuticals (ALXN) United States $22.618B 10.52
Seattle Genetics (SGEN) United States $20.666B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.190B 36.88
BioMarin Pharmaceutical (BMRN) United States $15.976B 0.00
Genmab (GNMSF) Denmark $14.806B 65.39
Alnylam Pharmaceuticals (ALNY) United States $14.487B 0.00
Galapagos (GLPG) Belgium $14.474B 37.29
Exact Sciences (EXAS) United States $12.931B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.431B 0.00
Sarepta Therapeutics (SRPT) United States $9.152B 0.00
QIAGEN (QGEN) Netherlands $8.272B 25.47
Guardant Health (GH) United States $7.994B 0.00
Bio-Techne Corp (TECH) United States $7.914B 54.16
BioNTech SE (BNTX) Germany $7.136B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.999B 0.00
Reata Pharmaceuticals (RETA) United States $6.906B 0.00
Ascendis Pharma (ASND) Denmark $6.762B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.685B 17.00
Amarin (AMRN) Ireland $6.498B 0.00
Exelixis (EXEL) United States $6.451B 18.15
Moderna (MRNA) United States $6.364B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.102B 0.00
Repligen (RGEN) United States $5.518B 100.00
Acceleron Pharma (XLRN) United States $5.006B 0.00
Bluebird Bio (BLUE) United States $4.881B 0.00
China Biologic Products (CBPO) China $4.581B 25.81
Adaptive Biotechnologies (ADPT) United States $3.948B 0.00
MorphoSys AG (MOR) Germany $3.881B 0.00
Mirati Therapeutics (MRTX) United States $3.814B 0.00
Blueprint Medicines (BPMC) United States $3.572B 0.00
Immunomedics (IMMU) United States $3.560B 0.00
NeoGenomics (NEO) United States $3.559B 189.36
Zai Lab (ZLAB) China $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.537B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.389B 57.41
Emergent Biosolutions (EBS) United States $3.293B 32.71
MyoKardia (MYOK) United States $3.269B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.251B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.171B 0.00
Genmab (GMAB) Denmark $3.099B 6.38
Halozyme Therapeutics (HALO) United States $3.095B 0.00
Alkermes (ALKS) Ireland $2.779B 220.13
Amicus Therapeutics (FOLD) United States $2.755B 0.00
UniQure (QURE) Netherlands $2.735B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.713B 6.31
Denali Therapeutics (DNLI) United States $2.517B 0.00
Epizyme (EPZM) United States $2.300B 0.00
Principia Biopharma (PRNB) United States $2.279B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Fate Therapeutics (FATE) United States $2.187B 0.00
Alector (ALEC) United States $1.998B 0.00
REGENXBIO (RGNX) United States $1.966B 0.00
Zymeworks (ZYME) Canada $1.900B 0.00
Ligand Pharmaceuticals (LGND) United States $1.722B 50.28
Arvinas (ARVN) United States $1.685B 0.00
Akcea Therapeutics (AKCA) United States $1.640B 0.00
Coherus BioSciences (CHRS) United States $1.554B 0.00
Zealand Pharma (ZEAL) Denmark $1.513B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Myriad Genetics (MYGN) United States $1.465B 25.85
Dicerna Pharmaceuticals (DRNA) United States $1.393B 0.00
Editas Medicine (EDIT) United States $1.381B 0.00
Intra-Cellular Therapies (ITCI) United States $1.327B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.225B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.216B 0.00
Revance Therapeutics (RVNC) United States $1.170B 0.00
PHARMA MAR SA (PHMMF) Spain $1.157B 0.00
Twist Bioscience (TWST) United States $1.083B 0.00
Adverum Biotechnologies (ADVM) United States $1.054B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Cytokineticsorporated (CYTK) United States $0.963B 0.00
Mesoblast (MESO) Australia $0.920B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
DBV Technologies S.A (DBVT) France $0.884B 0.00
Sangamo Therapeutics (SGMO) United States $0.867B 0.00
Vericel (VCEL) United States $0.848B 316.33
Codexis (CDXS) United States $0.827B 0.00
Heska (HSKA) United States $0.806B 205.94
ANI Pharmaceuticals (ANIP) United States $0.783B 13.36
Cellectis S.A (CLLS) France $0.723B 0.00
Intrexon (PGEN) United States $0.719B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.713B 6.00
Retrophin (RTRX) United States $0.710B 0.00
Cara Therapeutics (CARA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.665B 0.00
Intellia Therapeutics (NTLA) United States $0.657B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Kadmon Holdings (KDMN) United States $0.629B 0.00
UROGEN PHARMA (URGN) United States $0.625B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.608B 0.00
Anika Therapeutics (ANIK) United States $0.605B 19.63
NantKwest (NK) United States $0.584B 0.00
Arcus Biosciences (RCUS) United States $0.570B 0.00
AC Immune SA (ACIU) Switzerland $0.563B 13.03
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.540B 0.00
Agenus (AGEN) United States $0.536B 0.00
Cel-Sci (CVM) United States $0.533B 0.00
Puma Biotechnology (PBYI) United States $0.518B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
Bellus Health (BLU) Canada $0.507B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
BioDelivery Sciences (BDSI) United States $0.476B 0.00
Compugen (CGEN) Israel $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Sorrento Therapeutics (SRNE) United States $0.443B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.438B 0.00
Dynavax Technologies (DVAX) United States $0.429B 0.00
AnaptysBio (ANAB) United States $0.428B 0.00
Inovio Pharmaceuticals (INO) United States $0.428B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Precision BioSciences (DTIL) United States $0.415B 0.00
PDL BioPharma (PDLI) United States $0.414B 10.37
Cue Biopharma (CUE) United States $0.414B 0.00
Pfenex (PFNX) United States $0.411B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.410B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Mersana Therapeutics (MRSN) United States $0.407B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Gritstone Oncology (GRTS) United States $0.361B 0.00
Stemline Therapeutics (STML) United States $0.353B 0.00
CytomX Therapeutics (CTMX) United States $0.346B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Syros Pharmaceuticals (SYRS) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.306B 2.12
MannKind (MNKD) United States $0.303B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.301B 0.00
Aduro Biotech (ADRO) United States $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.294B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
WAVE Life Sciences (WVE) Singapore $0.287B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
IVERIC Bio (ISEE) United States $0.269B 0.00
Kamada (KMDA) Israel $0.268B 11.17
Geron (GERN) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Novavax (NVAX) United States $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.246B 0.00
Kala Pharmaceuticals (KALA) United States $0.241B 0.00
ChromaDex (CDXC) United States $0.239B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.237B 0.00
Protagonist Therapeutics (PTGX) United States $0.234B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.228B 11.69
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.218B 0.00
Alcobra (ARCT) United States $0.214B 0.00
Prometic Life Sciences (LMNL) Canada $0.214B 0.00
Arbutus Biopharma (ABUS) Canada $0.211B 0.00
Theratechnologies (THTX) Canada $0.211B 0.00
Cerecor (CERC) United States $0.210B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.207B 0.00
Affimed (AFMD) Germany $0.207B 0.00
TELA Bio (TELA) United States $0.205B 0.00
Fortress Biotech (FBIO) United States $0.204B 0.00
Exicure (XCUR) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.198B 0.00
Athersys (ATHX) United States $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 4.91
Abeona Therapeutics (ABEO) United States $0.179B 0.00
Spero Therapeutics (SPRO) United States $0.174B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Selecta Biosciences (SELB) United States $0.163B 0.00
Five Prime Therapeutics (FPRX) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Aptinyx (APTX) United States $0.156B 0.00
Verastem (VSTM) United States $0.153B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Celyad SA (CYAD) Belgium $0.151B 0.00
Liquidia Technologies (LQDA) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
ARAVIVE, INC (ARAV) United States $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.138B 0.00
Palatin Technologies (PTN) United States $0.137B 3.73
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.130B 0.00
Arsanis (XFOR) United States $0.127B 0.00
OvaScience (MLND) United States $0.125B 0.00
Prima BioMed (IMMP) Australia $0.118B 0.00
Clearside Biomedical (CLSD) United States $0.117B 0.00
Happiness Biotech Group (HAPP) China $0.117B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Applied Genetic Technologies (AGTC) United States $0.098B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Checkpoint Therapeutics (CKPT) United States $0.085B 0.00
AIT Therapeutics (XAIR) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.081B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Acorda Therapeutics (ACOR) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.077B 4.97
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Bioxytran (BIXT) United States $0.065B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Advaxis (ADXS) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
Soligenix (SNGX) United States $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.053B 0.00
Idera Pharmaceuticals (IDRA) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Celsion (CLSN) United States $0.030B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
IBio (IBIO) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00